24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics. - Wikidata - wikimedia - TriplyDB

24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

http://www.wikidata.org/entity/Q38051505

about

The application of the open pharmacological concepts triple store (Open PHACTS) to support drug discovery research Cross Talk between the Calcium-Sensing Receptor and the Vitamin D System in Prevention of Cancer Genetic mutation of p53 and suppression of the miR-17∼92 cluster are synthetic lethal in non-small cell lung cancer due to upregulation of vitamin D Signaling.CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells.Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer.Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.Peroxisome proliferator-activated receptor and vitamin d receptor signaling pathways in cancer cells.Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.Exploring vitamin D metabolism and function in cancer.Vitamin D3 Supplementation Reduces Subsequent Brain Injury and Inflammation Associated with Ischemic Stroke.An Excess of CYP24A1, Lack of CaSR, and a Novel lncRNA Near the PTH Gene Characterize an Ectopic PTH-Producing Tumor.Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma.

P2860

Q19845588-EED7197D-39C1-4787-96DE-5D99E7FC3BEC Q28078250-B117BF9D-5DCD-4DDB-9100-06DCF96BAEE6 Q35096787-6007CF63-9631-479A-87CB-C33EE7B51C89 Q36778121-F737EDBB-B6EF-4023-8271-C570E55CE87E Q37253471-A3A7A57E-F66A-4FE9-8AA8-26422AE0C073 Q37718405-51D8C04C-641F-426F-832A-8CF367A75B6B Q38160745-37E6248A-7CA7-4F7F-B4AE-70AE01DD2F1A Q47107773-C5255688-8122-4B7F-8C66-34E6C84E6BF8 Q52587327-C4970336-AA16-4637-AA40-63488289FAF1 Q52687545-12334519-AB38-4BF8-9490-C39C02CCD115 Q52738988-C671364C-ABD4-422C-8028-CAE26EA86CD4 Q53246434-7E11DC15-3894-42DB-9CB7-B185A651E833

P2860

24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

http://www.wikidata.org/entity/Q38051505

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

@en

type

label

24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

@en

prefLabel

24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

@en

P1433

Q38051505-F15ED80B-8151-489C-B0F4-EBF59C210CF9

P1476

Q38051505-BCFE371E-7502-4D55-ADEC-7D488302E82A

P2093

Q38051505-C14E0085-2540-4B61-97ED-531AD18935DC

Q38051505-C6389A0C-72A4-453F-B621-C3B5F205A055

Q38051505-CFF57564-EC83-4CE2-ABA8-2496BA763070

Q38051505-F97D1A84-551D-4877-B1CA-F9749C4E5079

P2860

Q38051505-0657B298-3130-4598-80EC-1C3E466B7D7C

Q38051505-0EC8E9D2-B4C2-47BE-B647-DF8246805EE4

Q38051505-110B8746-ADEE-4F0C-9F71-508F5A501D1D

Q38051505-13D6D35D-6FA6-4F9A-984A-23985240F4F9

Q38051505-1435659C-C5C3-442D-A239-6B011AC2DD6E

Q38051505-164AC2CF-D735-40DC-8677-B161145236FE

Q38051505-18C65FE3-34A7-4BA5-96F5-E7585D9DE7B6

Q38051505-190ED87D-7326-41E4-8498-A52DC9E96968

Q38051505-1D4C3900-9376-42F5-B6F1-84A4BED3B763

Q38051505-230A5044-B24C-42E1-AB32-59084276DB79

P304

Q38051505-32605BF9-A85B-4597-9987-45433A173FF2

P31

Q38051505-9886DDF2-4EC7-4313-BB1D-48BB81BFA2CD

P356

Q38051505-95F74FE7-F998-44B2-885A-384750A0F42B

P478

Q38051505-95317550-F154-4025-BF3D-EA60359B9807

P577

Q38051505-999D4A7B-11FA-4B99-BFA8-ED38F4704F35

P698

Q38051505-AE308235-908F-4475-93EA-A702CA21533A

P921

Q38051505-C1749748-7A94-42B5-970C-499DA291E042

P932

Q38051505-ACEA2126-1549-47BF-8985-4508234CDF3F

P356

J.JSBMB.2012.09.031

P1433

The Journal of Steroid Biochemistry and Molecular Biology

P1476

24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics.

@en

P2093

Candace S Johnson

http://www.w3.org/2001/XMLSchema#string

Donald L Trump

http://www.w3.org/2001/XMLSchema#string

Pamela A Hershberger

http://www.w3.org/2001/XMLSchema#string

Wei Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex

Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression

Transcriptional inhibition of CYP24 by genistein

Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants

Epigenetic regulation of vitamin D converting enzymes

Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450C24 (CYP24) promoter. Specific functions for ERK1/ERK2 and ERK5

Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2

P304

252-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSBMB.2012.09.031

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23059474

http://www.w3.org/2001/XMLSchema#string

P921

P932

3686893

http://www.w3.org/2001/XMLSchema#string